
NovoCure Limited NVCR
$ 17.24
0.35%
Country |
|
IPO year |
2015 |
Industry |
Health care |
Stock Exchange |
NASDAQ GLOBALSPB |
Shares |
111 M |
Market Cap[1] |
$ 1.92 B |
EBITDA (LTM) |
$ -62 M |
P/E (LTM) |
-22.22 |
P/S (LTM) |
3.51 |
EPS (LTM) |
-0.77 |
Other stocks of industry "Health care"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
|
Triple-S Management Corporation
GTS
|
- | 0.28 % | $ 847 M | NYSE | ||
|
Magellan Health, Inc.
MGLN
|
- | -0.19 % | $ 2.49 B | Nasdaq Global Select Market,SPB | ||
|
Anthem
ANTM
|
- | -2.32 % | $ 107 B | NYSE,SPB | ||
|
Molina Healthcare
MOH
|
$ 203.61 | 0.27 % | $ 10.8 B | NYSE,SPB | ||
|
UnitedHealth Group Inc.
UNH
|
$ 393.93 | 0.22 % | $ 358 B | NYSE,SPB | ||
|
Centene Corporation
CNC
|
$ 65.22 | 1.24 % | $ 32.2 B | NYSE,SPB | ||
|
CVS Health Corporation
CVS
|
$ 94.91 | 0.96 % | $ 120 B | NYSE,SPB | ||
|
Humana
HUM
|
$ 382.0 | 0.11 % | $ 46 B | NYSE,SPB | ||
|
Cigna Corporation
CI
|
$ 278.5 | 1.15 % | $ 73.4 B | NYSE,SPB |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.